{'fraction_non_alphanumeric': 0.016467065868263474, 'fraction_numerical': 0.0, 'mean_word_length': 5.623762376237623, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pregnancy, fertility, and inflammatory bowel disease.

Ideally, all women of childbearing age should discuss pregnancy plans with their general practitioner, gastroenterologist and any treating obstetrician and gynaecologist from the time of IBD diagnosis. In these discussions, practitioners should inform patients that pregnancy outcomes are very good when IBD is in remission and that active disease increases the risk to the baby. Establishing and documenting disease remission before conception and determining who is in the obstetric care team is important. Most IBD medications are low risk during pregnancy and breastfeeding, and their use should be continued.